Moreover, IL-6/STAT3 signaling is required for growth of CD44+CD24- stem cell-like breast cancer cells [8], a type of cells that play an important role in the clinical behavior of triple-negative breast cancer (TNBC) [9]. Here, STAT3 is linked to breast carcinoma.